دورية أكاديمية
Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis ; Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study
| العنوان: | Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis ; Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study |
|---|---|
| المؤلفون: | Diamond, Eli L., Subbiah, Vivek, Lockhart, A. Craig, Blay, Jean-Yves, Puzanov, Igor, Chau, Ian, Raje, Noopur S., Wolf, Jurgen, Erinjeri, Joseph P., Torrisi, Jean, Lacouture, Mario, Elez, Elena, Martínez-Valle, Ferran, Durham, Benjamin, Arcila, Maria E., Ulaner, Gary, Abdel-Wahab, Omar, Pitcher, Bethany, Makrutzki, Martina, Riehl, Todd, Baselga, José, Hyman, David M. |
| المصدر: | JAMA Oncology ; volume 4, issue 3, page 384 ; ISSN 2374-2437 |
| بيانات النشر: | American Medical Association (AMA) |
| سنة النشر: | 2018 |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1001/jamaoncol.2017.5029 |
| الإتاحة: | https://doi.org/10.1001/jamaoncol.2017.5029Test https://jamanetwork.com/journals/jamaoncology/fullarticle/2664827Test |
| رقم الانضمام: | edsbas.2CB6F922 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1001/jamaoncol.2017.5029 |
|---|